No tax




Security policy (edit with Customer reassurance module)


Delivery policy (edit with Customer reassurance module)


Return policy (edit with Customer reassurance module)


In a tube of aluminum 30 g ointment for external use. In the package 1 tube.

Mechanism of action

Chondroitin-AKOS ointment is a stimulator of cartilage tissue regeneration in the joints (chondroprotector). Chondroitin sulfate is a high molecular weight mucopolysaccharide, which is obtained from the cartilage of cattle trachea. Affects metabolic processes in hyaline and fibrous cartilage, reduces degenerative changes in the cartilage tissue of the joints, stimulates the biosynthesis of glycosaminoglycans in chondrocytes. Suppresses the activity of enzymes that cause damage to cartilage tissue, promotes the regeneration of the articular sacs and the cartilaginous surfaces of the joints, increases the production of intraarticular fluid. It improves Calcium and phosphorus metabolism and reduces calcium loss in cartilage, slows bone resorption, normalizes metabolism in hyaline tissue, accelerates regeneration processes. Structurally close to Heparin, it prevents the formation of fibrin clots in the synovial and subchondral microvasculature. As a result of exposure, pain decreases and mobility of the affected joints increases.
Dimethyl sulfoxide, which is part of the ointment, has anti-inflammatory, analgesic and fibrinolytic effects, contributes to a better penetration of chondroitin sulfate through the cell membrane into the tissue.
Ointment Chondroitin-AKOS has analgesic and anti-inflammatory effect, normalizes metabolism and stimulates recovery processes in the tissues of the joints, reduces and disappears pain in the joints, increases joint mobility and slows the progression of osteoarthritis and osteochondrosis.

Indications and usage

Treatment and prevention of osteochondrosis, osteoarthrosis of peripheral joints and the spine.


- Acute inflammatory process in the wound area at the site of the intended application of ointment.
- Common tissue necrosis.
- Excessive granulation, violation of the integrity of the skin in the place of the intended application of the ointment.
- Hypersensitivity to the drug.

Pregnancy and Breastfeeding

The need for a drug during pregnancy and lactation (breastfeeding), the doctor determines individually.

Dosage and administration

The ointment is applied 2-3 times / day on the skin over the lesion and rubbed for 2-3 minutes until completely absorbed. Usually the course of treatment ranges from 2-3 weeks to 2 months. If necessary, repeat the treatment.

Special notes

With the development of allergic reactions, the drug should be canceled. Avoid contact with the mucous membranes and open wounds. The need for use of the drug in children, the doctor determines individually.

Drug Interactions

There were no cases of negative drug interactions when prescribing Chondroitin-AKOS ointment while being treated with other drugs included in the conventional regimens for the treatment of degenerative diseases of the joints and spine.

Storage conditions

The drug should be stored in a dark place at a temperature of from 2 ° to 20 ° C.

3 years.

34 Items